- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BRAF V600 wildtype
Total 745 results
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterCompletedPathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8United States
-
Alnylam PharmaceuticalsActive, not recruitingTransthyretin Amyloidosis (ATTR) With CardiomyopathyUnited States, Poland, Argentina, Australia, Belgium, France, Germany, Japan, Netherlands, Portugal, Spain, Sweden, United Kingdom, Canada, Czechia, Denmark, Hungary, Ireland, Norway, Korea, Republic of, Austria, Croatia, Israel, Latvia, Lithuan... and more
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; Weill Medical College of Cornell UniversityActive, not recruiting
-
Novartis PharmaceuticalsCompletedBRAF-positive Metastatic MelanomaUnited States
-
Novartis PharmaceuticalsAvailable
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingMetastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC... and other conditionsUnited States
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungBelgium, Germany, United States, Canada, France, Italy, Japan, Korea, Republic of, Spain
-
University of VirginiaActive, not recruitingReal-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies (Lung001)Lung Cancer | ALK Gene Mutation | MET Gene Mutation | KRAS Mutation-Related Tumors | RET Gene Mutation | EGFR Gene Mutation | EGFR | ROS1 Gene Mutation | BRAFUnited States
-
Memorial Sloan Kettering Cancer CenterYale University; Dana-Farber Cancer InstituteActive, not recruitingLeukemia | Leukemia, Hairy Cell | Hairy Cell LeukemiaUnited States
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Pierre Fabre MedicamentPfizer; Merck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdCompletedBRAF V600E-mutant Metastatic Colorectal CancerFrance, Italy, United States, Spain, United Kingdom, Belgium, Austria, Japan, Netherlands
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruiting
-
ImmVira Pharma Co. LtdSuspendedMelanoma | Malignant MelanomaUnited States
-
Day One Biopharmaceuticals, Inc.Available
-
Anita TurkEli Lilly and CompanyTerminatedCancer | Cancer Metastatic | BRAF V600E | MEK1 Gene Mutation | MEK2 Gene Mutation | ERK Mutation | RAF1 Gene MutationUnited States
-
Stanford UniversityNovartis PharmaceuticalsCompletedAmeloblastoma | BRAF Gene MutationUnited States
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
Incyte CorporationActive, not recruitingGlioblastoma | Adult-type Diffuse GliomasUnited States, Spain, Italy, United Kingdom, Germany, Japan, France, Netherlands, Denmark
-
Pierre Fabre MedicamentMerck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic Colorectal Cancer | BRAF V600EChina
-
University of California, San FranciscoGenentech, Inc.Active, not recruitingPediatric Recurrent/Refractory BRAFV600E-mutant GliomasUnited States, Canada
-
Verastem, Inc.CompletedNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, Germany, Italy
-
Spanish Cooperative Group for the Treatment of...AmgenActive, not recruiting
-
Taiho Oncology, Inc.Institut de Recherches Internationales ServierCompletedRefractory Metastatic Colorectal CancerUnited States, Poland, France, Germany, Hungary, Italy, Russian Federation, Ukraine, Austria, Belgium, Brazil, Denmark, Puerto Rico, Spain
-
PfizerMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. Ltd; Pierre Fabre MedicamentCompletedBRAF V600E-mutant Metastatic Colorectal CancerUnited States, Spain, Korea, Republic of, United Kingdom, Australia, Czechia, Taiwan, Belgium, France, Hungary, Canada, Japan, Russian Federation, Netherlands, Israel, Germany, Turkey, Austria, Brazil, Poland, Italy, Argentina, Chile, Denmar... and more
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMelanoma of Unknown Primary | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Metastatic Malignant Neoplasm in Lymph NodeUnited States
-
UNICANCERHoffmann-La Roche; National Cancer Institute, France; Fondation ARCActive, not recruitingSolid Tumors | Hematologic Cancers | Metastatic CancersFrance
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Terminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Metastatic Malignant Neoplasm in the Brain | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
AstraZenecaMerck Sharp & Dohme LLCCompletedAdvanced Ovarian CancerUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungBelgium, Germany, Italy, France, Netherlands, Spain, Korea, Republic of, India, Brazil, Portugal
-
St. Justine's HospitalCHU de Quebec-Universite Laval; Montreal Children's Hospital of the MUHCActive, not recruitingLow-grade Glioma | Plexiform Neurofibroma | Central Nervous System GliomaCanada
-
Pierre Fabre MedicamentEuropean Organisation for Research and Treatment of Cancer - EORTCActive, not recruitingMelanomaSpain, Canada, Hungary, Italy, Belgium, Netherlands, Australia, Czechia, Greece, Brazil, Portugal, Serbia, Sweden, Norway, Germany, Argentina, Romania, Poland, United Kingdom, Austria, Switzerland, France, South Africa
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
Turning Point Therapeutics, Inc.Active, not recruitingAdvanced Solid Tumor | Metastatic Solid Tumors | MET Gene AlterationsUnited States, France, Korea, Democratic People's Republic of, Korea, Republic of, Spain
-
University of LouisvilleJames Graham Brown Cancer CenterWithdrawn
-
Ludwig-Maximilians - University of MunichActive, not recruitingMetastatic Colorectal CancerGermany
-
Sumitomo Pharma America, Inc.CompletedAdvanced Solid Tumors | Recurrent Ovarian Carcinoma | Colorectal Carcinoma | EGFR Positive Non-small Cell Lung Cancer | BRAF-Mutated MelanomaUnited States
-
Ludwig-Maximilians - University of MunichActive, not recruitingFOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC (AIO-KRK-0116)Metastatic Colorectal CancerGermany
-
Pierre Fabre MedicamentActive, not recruiting
-
Rain Oncology IncWithdrawnMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossMelanoma | Renal Cell Carcinoma | Gastric Cancer | NSCLC | Mesothelioma | Advanced Solid Tumor | Pancreas Adenocarcinoma | Urothelial Carcinoma Bladder | HNSCC | CDKN2A
-
Novartis PharmaceuticalsActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
Chandrikha ChandrasekharanAstraZeneca; Biocompatibles UK LtdSuspendedMetastatic Colorectal Cancer | Colorectal Neoplasms | Rectal Cancer | Colon Cancer | Colorectal Cancer Metastatic | Liver Metastases | Colo-rectal Cancer | Colorectal Carcinoma | Colorectal Adenocarcinoma | Liver Metastasis Colon CancerUnited States
-
Craig L Slingluff, JrCelldex TherapeuticsActive, not recruitingMelanoma | Ocular Melanoma | Uveal MelanomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Musella FoundationTerminatedGlioma | Glioblastoma | BRAF V600E | Pleomorphic Xantho-AstrocytomaUnited States
-
University Hospital, BordeauxCompletedWild-type Amyloid CardiopathyFrance
-
Institut du Cancer de Montpellier - Val d'AurelleMerck Serono International SACompleted
-
Massachusetts General HospitalIncyte CorporationTerminated